Novo Integrated Sciences ... (NVOS)
OTC: NVOS
· Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Apr 03, 2025, 10:15 AM
Novo Integrated Sciences Balance Sheet Statement
Financials in USD. Fiscal
year is
September - August.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Aug 31, 2024 | May 31, 2024 | Feb 29, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 | Feb 28, 2023 | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 | Nov 30, 2020 |
Cash & Equivalents | 844.58K | 1.54M | 651.75K | 1.64M | 416.32K | 464.01K | 609.74K | 878.7K | 2.18M | 12.68M | 15.94M | 8.8M | 8.29M | 8.37M | 1.7M | 1.97M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 522.06K | 370.83K | 692.74K | 310.65K | 520.34K | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 522.06K | 370.83K | 692.74K | 724.85K | 912.89K | 751.24K |
Receivables | 3.15M | 3.3M | 2.15M | 2.64M | 1.47M | 1.33M | 923.56K | 960.09K | 1.02M | 5.17M | 2.23M | 2.81M | 2.28M | 2.1M | 1.49M | 1.69M |
Inventory | 1M | 1.11M | 947.35K | 1.27M | 1.11M | 938.94K | 925.11K | 1.01M | 879.03K | 645.06K | 334.41K | 364.15K | 339.38K | 1.00 | 1.00 | n/a |
Other Current Assets | 417.28K | 214.44K | 217.62K | 213.81K | 346.17K | 221.41K | 546.6K | 554.98K | 571.34K | 380.8K | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 5.41M | 6.16M | 5.02M | 6.81M | 4.39M | 4M | 4.05M | 4.46M | 5.73M | 20.08M | 19.02M | 12.24M | 11.13M | 10.83M | 3.6M | 4.15M |
Property-Plant & Equipment | 6.8M | 6.95M | 7.16M | 7.18M | 7.37M | 7.51M | 7.7M | 7.99M | 8.47M | 8.15M | 8.51M | 8.54M | 8.61M | 3.09M | 2.88M | 3M |
Goodwill & Intangibles | 19.92M | 22.21M | 22.77M | 23.26M | 23.8M | 24.24M | 24.74M | 25.3M | 26.67M | 43.56M | 42.28M | 42.78M | 41.52M | 27.58M | 27.46M | 26.93M |
Total Long-Term Assets | 26.73M | 29.17M | 29.93M | 30.44M | 31.17M | 31.75M | 32.44M | 33.29M | 35.14M | 51.71M | 51.3M | 51.69M | 50.82M | 31.4M | 31.25M | 30.68M |
Total Assets | 32.14M | 35.33M | 34.95M | 37.24M | 35.56M | 35.75M | 36.49M | 37.75M | 40.87M | 71.79M | 70.32M | 63.93M | 61.96M | 42.23M | 34.86M | 34.84M |
Account Payables | 3.24M | 3.89M | 2.17M | 3.4M | 3.51M | 1.9M | 2.04M | 2.08M | 1.8M | 1.62M | 1.11M | 1.31M | 1.45M | 849.3K | 901.42K | 895.43K |
Deferred Revenue | n/a | n/a | 1.81M | 35.07K | 35.43K | 35.64K | 35.44K | 35.78K | 36.89K | 38.56K | 38.63K | 38.31K | 38.63K | n/a | n/a | n/a |
Short-Term Debt | 3.16M | 2.49M | 2.29M | 2.57M | 2.29M | 2.28M | 1.89M | 6.84M | 9.1M | 7.59M | 7.31M | 11.32M | 4.96M | 1.12M | 610.77K | 83.54K |
Other Current Liabilities | 8.19M | 15.59M | 4.69M | 4.27M | 1.41M | 1.31M | 62.39K | 1.45M | 534.6K | 2.77M | 2.39M | 2.23M | 1.22M | 858.5K | 1.34M | 918.14K |
Total Current Liabilities | 14.58M | 22.68M | 9.96M | 10.92M | 7.9M | 6.21M | 6.18M | 12.57M | 14.07M | 12.73M | 11.55M | 15.65M | 8.46M | 3.52M | 3.66M | 2.59M |
Long-Term Debt | 1.55M | 63.57K | 1.7M | 63.78K | 65.04K | 64.95K | 64.98K | 1.08M | 1.11M | 11.39M | 10.88M | 1.14M | 6.12M | 39.54K | 2.06M | 955.9K |
Other Long-Term Liabilities | n/a | n/a | -1.64M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.06M | n/a |
Total Long-Term Liabilities | 2.95M | 2.99M | 3.1M | 3.04M | 3.16M | 3.25M | 3.35M | 4.5M | 4.75M | 14.63M | 14.25M | 4.61M | 9.69M | 2.09M | 2.06M | 3.09M |
Total Liabilities | 17.53M | 25.66M | 13.06M | 13.96M | 11.06M | 9.45M | 9.53M | 17.06M | 18.83M | 27.36M | 25.81M | 20.27M | 18.15M | 5.62M | 5.72M | 5.69M |
Total Debt | 4.71M | 4.5M | 5.34M | 4.64M | 4.47M | 4.58M | 4.34M | 10.47M | 13M | 21.29M | 20.61M | 14.98M | 13.71M | 3.73M | 4.1M | 3.73M |
Book Value | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Book Value Per Share | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock | 19.05K | 19.05K | 17.75K | 17.29K | 15.76K | 144.86K | 139.63K | 39.89K | 3.12K | 30.66K | 28.89K | 28.64K | 26.61K | 26.49K | 23.8K | 235.53K |
Retained Earnings | -83.2M | -88.2M | -74.46M | -71.71M | -67.03M | -63.87M | -62.38M | -57.75M | -53.82M | -31.39M | -27.58M | -22.78M | -20.97M | -19.03M | -18.62M | -17.28M |
Comprehensive Income | n/a | 1.45M | 503.38K | -246.49K | -357.38K | -172.53K | -51.99K | 143.83K | 560.84K | 1.02M | 1M | 887.54K | 991.08K | 1.38M | 1.25M | 1.21M |
Shareholders Equity | 14.89M | 9.96M | 22.19M | 23.58M | 24.82M | 26.57M | 27.25M | 20.95M | 22.31M | 44.37M | 44.55M | 43.64M | 43.86M | 36.67M | 29.19M | 29.2M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 522.06K | 370.83K | 692.74K | 310.65K | 520.34K | n/a |